Does Rallies show 13F holders for IMNN?

Yes. Rallies tracks hedge fund and 13F ownership data for IMNN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is IMNN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IMNN. It does not provide personalized investment advice.

IMNN (Imunon, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Imunon, Inc. Common Stock (IMNN) is a publicly traded Healthcare sector company. As of May 21, 2026, IMNN trades at $2.21 with a market cap of $9.50M and a P/E ratio of -0.32. IMNN moved -1.35% today. Year to date, IMNN is -46.08%; over the trailing twelve months it is -63.10%. Its 52-week range spans $2.08 to $41.22. Analyst consensus is strong buy with an average price target of $15.67. Rallies surfaces IMNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns IMNN stock?

Hedge funds tracked by Rallies that own IMNN include Renaissance Technologies, Citadel Advisors, and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Imunon, Inc. Common Stock.

IMNN Key Metrics

Key financial metrics for IMNN
Metric	Value
Price	$2.21
Market Cap	$9.50M
P/E Ratio	-0.32
EPS	$-6.83
Dividend Yield	0.00%
52-Week High	$41.22
52-Week Low	$2.08
Volume	5.52K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-14.50M
Gross Margin	0.00%

Top Hedge Funds Holding IMNN

Renaissance Technologies holds 33.56K shares of IMNN, changed -47.24% as of Dec 31, 2024.
Citadel Advisors holds 12.82K shares of IMNN, changed -62.26% as of Dec 31, 2024.
Two Sigma holds 10.52K shares of IMNN, changed -23.99% as of Sep 30, 2024.

Latest IMNN News

Imunon Outlines Q1 2026 Clinical Milestones and Funding Strategy — May 12, 2026
IMUNON Q1 Loss $4.3M and $4.8M Cash, Phase 2 Shows 14.7-Month OS Gain — May 12, 2026
Imunon’s OVATION 2 Survival Improves to 14.7 Months, Phase 3 Funding Plans Underway — Mar 31, 2026
IMUNON’s IMNN-001 Shows 14.7-Month OS Gain, Phase 3 Enrollment Ahead — Mar 31, 2026

Recent IMNN Insider Trades

Braun Donald P bought 25.00K (~$29.48K) on Aug 20, 2024.
Lindborg Stacy bought 25.00K (~$24.50K) on Aug 15, 2024.
Tardugno Michael H bought 25.00K (~$25.75K) on Aug 15, 2024.

IMNN Analyst Consensus

3 analysts cover IMNN: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.67.

Common questions about IMNN

Who owns IMNN stock?: Hedge funds tracked by Rallies that own IMNN include Renaissance Technologies, Citadel Advisors, and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Imunon, Inc. Common Stock.
Does Rallies show 13F holders for IMNN?: Yes. Rallies tracks hedge fund and 13F ownership data for IMNN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is IMNN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IMNN. It does not provide personalized investment advice.